Pulsenmore (PLSM) Other Accumulated Expenses (2025)

Pulsenmore (PLSM) reported Other Accumulated Expenses of $1.4 million for Q4 2025.

Pulsenmore (PLSM) Other Accumulated Expenses (2025) Analysis & Trends

Pulsenmore (PLSM) has 1 years of Other Accumulated Expenses data on file, last reported at $1.4 million in Q4 2025.

For the quarter ending Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (changed N/A YoY), and the FY2025 full-year result was $1.4 million, changed N/A from the prior year.
Other Accumulated Expenses was little changed at $1.4 million in Q4 2025.
In the past five years, Other Accumulated Expenses ranged from a high of $1.4 million in Q4 2025 to a low of $1.4 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	181.33 Bn	174.04 Bn	6.27 Bn
2	Stryker	128.11 Bn	125.23 Bn	3.81 Bn
3	Medtronic	107.76 Bn	98.54 Bn	6.41 Bn
4	Boston Scientific	67.95 Bn	66.50 Bn	3.61 Bn
5	Edwards Lifesciences	47.64 Bn	43.97 Bn	1.29 Bn
6	GE HealthCare Technologies	28.43 Bn	26.14 Bn	1.98 Bn
7	Dexcom	28.31 Bn	27.20 Bn	750.30 Mn
8	Smith & Nephew	26.77 Bn	26.19 Bn	-
9	Koninklijke Philips	25.33 Bn	22.21 Bn	2.07 Bn
10	Pulsenmore	22.55 Mn	876,817.50	-

Download Data

Date	Value
Dec 31, 2025	1.38 Mn